EdwardL.MorrisMD, M.S., FACR, FACP

PubMed

• 14 citations
  Cerebral vasculopathy associated with collateralization resembling moya moya phenomenon and with anti-Ro/SS-A and anti-La/SS-B antibodies.
  Thomas T. Provost, Howard Moses, Edward L. Morris, Jeremy Altman, John B. Harley
  Arthritis and Rheumatism. 1991-08-01
• 9 citations
  Agranulocytosis and sulindac.
  Edward L. Morris, Marc C. Hochberg, Carole A. Dorsch
  Arthritis and Rheumatism. 1981-05-01

Journal Articles

• Similarities & Differences:Rheumatoid Arthritis & Systemic Lupus Erythematosus  
  Morris EL, Lupus Update, 1/1/1999
• SLE in the Male: A Different Disease?  
  Morris EL, Lupus Update, 1/1/1992
• Cerebral Vasculopathy Associated with Collateralization Resembling Moya Moya and Anti-Ro(SSA) and La(SSB) Antibodies  
  Provost, TT, Moses, H, Morris, EL, Altman, J, Harley, JB, Alexander, E, Reichlin, M, Arthritis and Rheumatism, 1/1/1991
• Lupus and Men  
  Morris EL, Lupus Update, 1/1/1989
• Arthritis Comes in Many Forms  
  Morris EL, Senior Digest, 1/1/1987
• Connective Tissue Subject to Attack by Diseases  
  Morris EL, Senior Digest, 1/1/1987
• Agranulocytosis and Sulindac  
  Morris, EL, Hochberg, MC, Dorsch, CA, Arthritis and Rheumatism, 1/1/1981
• Rheumatoid Arthritis - A Sequel to HBsAg Hepatitis  
  Morris, EL, Stevens, MB, American Journal of Medicine, 1/1/1978
• Join now to see all

Abstracts/Posters

• Fluorescent Antinuclear Antibody FANA) Negative, Anti-Single Stranded (ss) DNA-Positive Sera: Frequency and Clinical Significance in a Rheumatic Disease Population.
  Morris, EL, Hochberg, MC, Dorsch, CA, Clinical Research; American Rheumatism Association Southeastern Division, 1/1/1980

Lectures

• Update on Nonsteroidal Anti-inflammatory Agents and the New COX-II Inbititor 
  1/25/1999
• Reappraisal of the Management of Ostoearthritis 
  Union Memorial Hospital - 1/25/1999
• The Science of COX II Technology 
  Six Flags’ America, Largo, MD - 1/25/1999
• Cox II Technology/Osteoporosis Update 
  Finksburg, MD - 1/24/1999
• Reappraisal of the Treatment of Osteoarthritis 
  City Hospital, Martinsberg, WV, 1998; McNeil, Fallston, MD, 1999 - 1/23/1999
• Frederick, MD 
  Bay Lady, Baltimore, MD - 1/23/1999
• Reappraisal of the Management of Osteoarthritis 
  Frederick, MD - 1/22/1999
• Evaluation and Management of Osteoporosis 
  1/20/1999
• Update on Nonsteroidal Usage 
  Sinai Hospital, Baltimore, MD - 1/17/1999
• Osteoarthritis and Newer NSAID’s 
  Finksburg, MD - 1/17/1999
• Update on COX-II Technology 
  Baltimore, MD - 1/13/1999
• Use of Nonsteroidal Anti-inflammatory Agents and the New COX-II Inhibitor. 
  Union Memorial Hospital - 1/12/1999
• Update on the Management of Osteoarthritis 
  Shady Grove Hospital, Bethesda, MD - 1/11/1999
• Update on Nonsteroidal Anti-inflammatory Agents and the New COX-II Inhibitor 
  1/7/1999
• Management of Rheumatoid Arthritis 
  Hoechst, Marion, Rouseau, Hagerstown, MD - 1/4/1999
• Update on the Nonsteroidal Usage 
  Towson, MD - 1/4/1999
• Current Concepts in the Treatment of Osteoarthritis 
  Inova Fairfax Hospital, Fairfax, VA - 1/31/1998
• The Safety of OTC Analgesics 
  Franklin Square Hospital, Baltimore, MD - 1/12/1998
• Update on the Safe Usage of NSAID’s 
  Maryland General Hospital, Baltimore, MD - 1/8/1998
• Distinguishing Osteoarthritis from Rheumatoid Arthritis 
  Baltimore, MD - 1/3/1998
• The Challenge of Diagnosis and Treating Osteoporosis 
  Baltimore, MD - 1/28/1997
• Osteoporosis 
  Northwest Hospital Center, Baltimore, MD - 1/22/1997
• Update on Osteoporosis 
  Baltimore, MD - 1/20/1997
• Differential Diagnosis of Osteoarthritis and Rheumatoid Arthritis 
  Baltimore, MD - 1/12/1997
• Osteoporosis Update, Bone Densitometry Testing 
  Mansfield, OH - 1/10/1997
• Join now to see all